Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Regencell Bioscience Holdings Limited (RGC) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.58M |
|
-- |
|
-- |
|
$3.77M |
|
$-3.77M |
|
$0.19M |
|
$-3.58M |
|
$-3.58M |
|
$-3.58M |
|
$-3.58M |
|
$-3.58M |
|
$-3.58M |
|
$-3.77M |
|
$-3.69M |
|
494.49M |
|
494.49M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$4.90M |
|
$0.22M |
|
$0.85M |
|
$5.76M |
|
$0.66M |
|
-- |
|
$0.23M |
|
$0.90M |
|
$4.86M |
|
$4.86M |
|
$4.86M |
|
494.49M |
|
| Cash Flow Statement Financials | |
$-3.11M |
|
$2.69M |
|
-- |
|
$2.96M |
|
$2.42M |
|
$-0.54M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.39 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-73.75% |
|
-73.75% |
|
-62.27% |
|
-73.75% |
|
$0.01 |
|
$-0.01 |
|
$-0.01 |
|